197 related articles for article (PubMed ID: 35780135)
1. A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center.
Zhu YL; Ren WH; Wang Q; Jin HZ; Guo YY; Lin DM
Diagn Pathol; 2022 Jul; 17(1):56. PubMed ID: 35780135
[TBL] [Abstract][Full Text] [Related]
2. Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.
Straccia P; Chiappetta M; Magnini D; Cancellieri A
Cytopathology; 2022 May; 33(3):305-311. PubMed ID: 35213747
[TBL] [Abstract][Full Text] [Related]
3. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
[TBL] [Abstract][Full Text] [Related]
4. Categorisation of peritoneal serous effusions using the International System for Reporting Serous Fluid Cytopathology-A study on gynaecological samples.
Rakheja G; Singh M; Priyadarshnee B; Marimuthu B; Dhar L; Jain S; Khurana N; Rathore A
Cytopathology; 2023 Mar; 34(2):138-145. PubMed ID: 36530023
[TBL] [Abstract][Full Text] [Related]
5. A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.
Rajeswaran PK; Srinivasan V; Mahesh SSV; Ashok AU
Acta Cytol; 2023; 67(1):70-79. PubMed ID: 36476509
[TBL] [Abstract][Full Text] [Related]
6. Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.
Ahuja S; Malviya A
Cytopathology; 2022 Mar; 33(2):176-184. PubMed ID: 34913541
[TBL] [Abstract][Full Text] [Related]
7. The International System for Reporting Serous Fluid Cytopathology: An Institutional Experience on its Implication and Assessment of Risk of Malignancy in Effusion Cytology.
Kala C; Kala S; Singh A; Jauhari RK; Bajpai A; Khan L
J Cytol; 2023; 40(4):159-164. PubMed ID: 38058672
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan.
Lu CH; Liu CY; Jhuang JY; Chen CC
Cancer Cytopathol; 2024 Mar; 132(3):169-178. PubMed ID: 38062987
[TBL] [Abstract][Full Text] [Related]
9. Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk.
Wang M; Sun T; Jiao J; Wang H
Cancer Cytopathol; 2023 Jul; 131(7):433-441. PubMed ID: 36973963
[TBL] [Abstract][Full Text] [Related]
10. Cytohistological Correlation in Pleural Effusions Based on the International System for Reporting Serous Fluid Cytopathology.
Pinto D; Cruz E; Branco D; Linares C; Carvalho C; Silva A; Chorão M; Schmitt F
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34203073
[TBL] [Abstract][Full Text] [Related]
11. Deciphering Serous Effusions Using the New International System for Reporting Serous Fluid Cytopathology.
Mandava H; Venkata Renuka I; Potti R; Mounica B; Kalla I
Cureus; 2024 May; 16(5):e60042. PubMed ID: 38774462
[TBL] [Abstract][Full Text] [Related]
12. Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies.
Sun T; Wang M; Wang H
Cancer Cytopathol; 2022 Dec; 130(12):964-973. PubMed ID: 35994357
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of pleural effusion specimens based on the newly proposed International System for Reporting Serous Fluid Cytopathology.
Xu Y; Hu AY; Wang SM; Wang Q; Pan YC; Zhang SH
Diagn Cytopathol; 2021 Sep; 49(9):997-1007. PubMed ID: 34019334
[TBL] [Abstract][Full Text] [Related]
14. Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.
Sachan R; Gupta A; Awasthi PN; Singh P; Anand N; Chandra S; Gaur G; Husain N; Sachan KD
J Am Soc Cytopathol; 2023; 12(5):351-361. PubMed ID: 37244848
[TBL] [Abstract][Full Text] [Related]
15. A single tertiary institution review of the international system for serous fluid cytopathology and the impact of cell block and ancillary studies on its performance.
Lim KH; Ahmed SS; Cheng XM; Hwang JSG; Karunanithi J; Mantoo S; Takano AM; Sultana R; Khor LY
J Am Soc Cytopathol; 2023; 12(1):48-57. PubMed ID: 36192336
[TBL] [Abstract][Full Text] [Related]
16. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in reporting serous effusion: A retrospective study.
Yang H; Zhu J; Wang P
Medicine (Baltimore); 2023 Oct; 102(43):e35707. PubMed ID: 37904355
[TBL] [Abstract][Full Text] [Related]
17. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.
Rodriguez EF; Jones R; Gabrielson M; Santos D; Pastorello RG; Maleki Z
Acta Cytol; 2020; 64(5):477-485. PubMed ID: 32422631
[TBL] [Abstract][Full Text] [Related]
18. The value of a tiered cytology diagnostic reporting system in assessing the risk of malignancy in indeterminate serous effusions.
Hou T; Landon G; Stewart J; Roy-Chowdhuri S
Cancer Cytopathol; 2021 Jan; 129(1):75-82. PubMed ID: 32809259
[TBL] [Abstract][Full Text] [Related]
19. Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment.
Pergaris A; Stefanou D; Keramari P; Sousouris S; Kavantzas N; Gogas H; Mikou P
Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943460
[TBL] [Abstract][Full Text] [Related]
20. The Role of Novel Tiered Reporting System in Serous Fluid Cytology and Risk of Malignancy Assessment: A Retrospective Study in a Tertiary Care Center.
Alashetty S; Sadasivan B; Dharmalingam P; Rajagopal N; Kavya L; Pai MM
J Cytol; 2023; 40(3):107-113. PubMed ID: 37745807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
